Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery

Clinical trial NCT00796887 · COMPLETED

Trial details

NCT number: NCT00796887
Sponsor: Henry Ford Health System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2009-04-01
Primary completion: 2012-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.